A detailed history of Smartleaf Asset Management LLC transactions in Argenx Se stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 89 shares of ARGX stock, worth $54,872. This represents 0.01% of its overall portfolio holdings.

Number of Shares
89
Previous 38 134.21%
Holding current value
$54,872
Previous $16.9 Million 182.21%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$434.22 - $551.9 $22,145 - $28,146
51 Added 134.21%
89 $47.7 Million
Q2 2024

Aug 13, 2024

BUY
$356.01 - $451.55 $8,544 - $10,837
24 Added 171.43%
38 $16.9 Million
Q1 2024

Oct 07, 2024

SELL
$356.95 - $413.29 $8,566 - $9,918
-24 Reduced 63.16%
14 $5.58 Million
Q1 2024

May 02, 2024

BUY
$356.95 - $413.29 $713 - $826
2 Added 16.67%
14 $5.32 Million
Q4 2023

Feb 12, 2024

BUY
$338.91 - $506.01 $4,066 - $6,072
12 New
12 $4.56 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.1B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.